España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Stoke Therapeutics
STOK
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$8.33
-0.41
-4.69%
At close: -
$8.40
0.07
0.84%
After Hours: 5:44 PM EDT
Get Report
Comment
Stoke Therapeutics (STOK) Forecast
News
Earnings
Stoke Therapeutics (STOK) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Stoke Therapeutics (NASDAQ:STOK) Stock
Stoke Therapeutics Stock (NASDAQ: STOK)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, February 19, 2025
Chardan Capital Maintains Buy on Stoke Therap...
Benzinga Newsdesk
Tuesday, February 18, 2025
Biogen Strengthens Pipeline With Stoke Therapeutic's Dravet Syndrome Candidate Via Multi-Million Dollar Deal
Vandana Singh
Needham Reiterates Buy on Stoke Therapeutics,...
Benzinga Newsdesk
HC Wainwright & Co. Maintains Buy on Stoke Th...
Benzinga Newsdesk
Biogen And Stoke Therapeutics Enter Into Coll...
Benzinga Newsdesk
Tuesday, February 11, 2025
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Wednesday, January 08, 2025
HC Wainwright & Co. Maintains Buy on Stoke Th...
Benzinga Newsdesk
The Analyst Verdict: Stoke Therapeutics In The Eyes Of 4 Experts
Benzinga Insights
Needham Maintains Buy on Stoke Therapeutics, ...
Benzinga Newsdesk
Tuesday, January 07, 2025
Stoke Therapeutics Announced Alignment With G...
Benzinga Newsdesk
Monday, January 06, 2025
Stoke Therapeutics To Host Webcast To Discuss...
Benzinga Newsdesk
Friday, December 20, 2024
Chardan Capital Initiates Coverage On Stoke T...
Benzinga Newsdesk
Tuesday, December 10, 2024
Cantor Fitzgerald Reiterates Overweight on St...
Benzinga Newsdesk
Friday, December 06, 2024
Stoke Therapeutics Reports New OLE Study Data...
Benzinga Newsdesk
Thursday, December 05, 2024
GeneDx Announces Biogen, Praxis Precision Med...
Benzinga Newsdesk
Wednesday, December 04, 2024
Pure Storage Posts Upbeat Results, Joins Cross Country Healthcare, Marvell Technology, Stoke Therapeutics And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
Stoke Therapeutics shares are trading higher ...
Benzinga Newsdesk
Stoke Therapeutics Announced That It Has Rece...
Benzinga Newsdesk
Monday, December 02, 2024
Stoke Therapeutics Announces Plans To Present...
Benzinga Newsdesk
Wednesday, November 06, 2024
Stoke Therapeutics shares are trading higher ...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Stoke T...
Benzinga Newsdesk
Needham Reiterates Buy on Stoke Therapeutics,...
Benzinga Newsdesk
Tuesday, November 05, 2024
Stoke Therapeutics Q3 2024 GAAP EPS $(0.47) B...
Benzinga Newsdesk
Monday, September 23, 2024
Skorpios Trust Reports 16.9% Stake In Stoke T...
Benzinga Newsdesk
Wednesday, September 11, 2024
HC Wainwright & Co. Reiterates Buy on Stoke T...
Benzinga Newsdesk
Tuesday, September 10, 2024
Stoke Therapeutics Presents Zorevunersen Data...
Benzinga Newsdesk
Tuesday, September 03, 2024
Stoke Therapeutics To Present Encore Data Tha...
Benzinga Newsdesk
Thursday, August 08, 2024
Needham Reiterates Buy on Stoke Therapeutics,...
Benzinga Newsdesk
Wednesday, August 07, 2024
FDA Removes Partial Clinical Hold On Zorevune...
Benzinga Newsdesk
Stoke Therapeutics Q2 2024 GAAP EPS $(0.46) B...
Benzinga Newsdesk
Thursday, July 11, 2024
Wedbush Reiterates Outperform on Stoke Therap...
Benzinga Newsdesk
Friday, June 28, 2024
A Closer Look at 5 Analyst Recommendations For Stoke Therapeutics
Benzinga Insights
Needham Reiterates Buy on Stoke Therapeutics,...
Benzinga Newsdesk
Monday, June 24, 2024
Enerpac Tool Group, Singular Genomics Systems And 3 Stocks To Watch On Monday
Avi Kapoor
Friday, June 21, 2024
Stoke Therapeutics Announces Chief Operating ...
Benzinga Newsdesk
Tuesday, May 07, 2024
Canaccord Genuity Maintains Buy on Stoke Ther...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Stoke T...
Benzinga Newsdesk
Monday, May 06, 2024
Analyst Expectations For Stoke Therapeutics's Future
Benzinga Insights
Needham Reiterates Buy on Stoke Therapeutics,...
Benzinga Newsdesk
Stoke Therapeutics Q1 2024 GAAP EPS $(0.57) B...
Benzinga Newsdesk
Monday, April 29, 2024
Stoke Therapeutics Appoints Thomas Leggett As...
Benzinga Newsdesk
Thursday, April 11, 2024
Needham Reiterates Buy on Stoke Therapeutics,...
Benzinga Newsdesk
Friday, April 05, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Thursday, April 04, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Assessing Stoke Therapeutics: Insights From 6 Financial Analysts
Benzinga Insights
Cantor Fitzgerald Reiterates Overweight on St...
Benzinga Newsdesk
Thursday, March 28, 2024
Stoke Therapeutics shares are trading lower a...
Benzinga Newsdesk
Stoke Therapeutics Prices Upsized $125M Publi...
Benzinga Newsdesk
Wednesday, March 27, 2024
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Stoke Therapeutics shares are trading higher....
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
